Syneos Health, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Share-based compensation
Provision for doubtful accounts
(Benefit from) provision for deferred income taxes
Foreign currency transaction adjustments
Asset impairment charges
Fair value adjustment of contingent obligations
Gain on sale of business
Loss on extinguishment of debt
Other non-cash items

Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, unbilled services, and deferred revenue
Accounts payable and accrued expenses
Other assets and liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Payments related to acquisitions of businesses, net of cash acquired
Proceeds from notes receivable from divestiture
Proceeds from sale of business
Purchases of property and equipment
Other, net
Investments in unconsolidated affiliates
Loan to unconsolidated affiliate
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from issuance of long-term debt, net of discount
Payments of debt financing costs
Repayments of long-term debt
Proceeds from accounts receivable financing agreement
Repayments of accounts receivable financing agreement
Proceeds from revolving line of credit
Repayments of revolving line of credit
Redemption of Senior Notes and associated breakage fees
Payments of contingent consideration related to acquisitions
Payments of finance leases
Payments for repurchases of common stock
Proceeds from exercises of stock options
Payments related to tax withholdings for share-based compensation
Net cash (used in) provided by financing activities

Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Net change in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash - beginning of period
Cash, cash equivalents, and restricted cash - end of period

Comments